{"prediction": {"id": "a8530184-3dbd-5218-a780-72ef57f7da86", "work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "study_id": "76c1e1e8-7914-56b7-afa5-df263cc0f539", "kind": "Model scenario comparison", "pages": [1], "version": "Version of record", "source_work_id": "5714d41f-bedc-511e-9b2c-8a342e09c664", "title": "Osimertinib Optimal Dosing Through Population Pharmacokinetics in Virtual Patients with NSCLC: An Approach Integrating Multiple Studies.", "doi": "10.3390/pharmaceutics18101332", "pdf_sha256": "53cc633b5136d3a11718f6f759527824b58ba1c6ef4c72d198ce55a1643f257a", "physical_page_count": 15}, "fields": {"endpoint": {"value": "plasma_drug_exposure", "source_basis": "verified_profile", "pages": [1]}, "family": {"value": "pharmacokinetic_exposure", "source_basis": "verified_profile", "pages": [1]}, "measured_variable": {"value": "plasma_drug_exposure", "source_basis": "verified_profile", "pages": [1]}, "measurement_role": {"value": "exposure_outcome", "source_basis": "original_pdf_review", "pages": [1]}, "model": {"value": "mechanistic_or_numerical", "source_basis": "verified_profile", "pages": [1]}, "role": {"value": "simulated_exposure", "source_basis": "verified_profile", "pages": [1]}, "scenario": {"value": "virtual_body_weight_and_albumin_strata_comparison", "source_basis": "verified_profile", "pages": [1]}}, "endpoints": [{"term": "pharmacokinetics", "label": "Pharmacokinetics and drug exposure"}], "validations": [], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}